Sign inJoin waitlistJoin the waitlist

KC

Kevin Curran

Assistant Attending, Pediatric Bone Marrow Transplant Service · New York Presbyterian Hospital

Credentials: · ·

History

New York Presbyterian Hospital
Present

Memorial Sloan Kettering Cancer Center
2007–2008
Tufts Medical Center
2004–2007
Georgetown University School of Medicine
2000–2004

Research

ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
Review · Biology of Blood and Marrow Transplantation · 2019 · 3,048 citations
Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
New England Journal of Medicine · 2018 · 2,239 citations
Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia
Science Translational Medicine · 2014 · 2,062 citations

JP
Jae Park
21 papers
Renier Brentjens
21 papers
Richard O’Reilly
20 papers
AS
Andromachi Scaradavou
19 papers
NK
Nancy Kernan
19 papers
Susan Prockop
19 papers
JB
Jaap-Jan Boelens
18 papers
Liora Schultz
17 papers
Theodore Laetsch
17 papers
Vanessa Fabrizio
17 papers · 7 as a fellow
Amy Moskop
16 papers · 6 as a fellow
Amy Keating
15 papers

Clinical trials

A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia
Principal investigator · Recruiting · Phase 3
Memorial Sloan Kettering Cancer Center
2025–2028
A Second Infusion (Early Reinfusion) of Tisagenlecleucel in Children and Young Adults With B-Cell Acute Lymphoblastic Leukemia(B-ALL)
Principal investigator · Active not recruiting · Phase 2
Memorial Sloan Kettering Cancer Center
2022–2027
A Modified Dose of Rabbit Anti-thymocyte Globulin (rATG) in Children and Adults Receiving Treatment to Help Prepare Their Bodies for a Bone Marrow Transplant
Principal investigator · Active not recruiting · Phase 2
Memorial Sloan Kettering Cancer Center
2021–2027
T-Lymphocytes Genetically Targeted to the B-Cell Specific Antigen CD19 in Pediatric and Young Adult Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
Principal investigator · Active not recruiting · Phase 1
Memorial Sloan Kettering Cancer Center
2013–2027